GMED vs SOLV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 28, 2026

GMED

61.7
AI Score
VS
GMED Wins

SOLV

49.5
AI Score

Investment Advisor Scores

GMED

62score
Recommendation
BUY

SOLV

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GMED SOLV Winner
Forward P/E 21.2766 12.4378 SOLV
PEG Ratio 1.7253 1.4017 SOLV
Revenue Growth 22.9% 0.7% GMED
Earnings Growth 131.6% 931.4% SOLV
Tradestie Score 61.7/100 49.5/100 GMED
Profit Margin 15.3% 18.1% SOLV
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD GMED

Frequently Asked Questions

Based on our detailed analysis, GMED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.